FASLG and autoimmune polyendocrinopathy: Given the favourablerisk/benefit ratio of heparin/aspirin treatment during pregnancy for obstetric APS itappears reasonable, at present, to offer this treatment during pregnancy to women withlow-titre aPL associated with obstetric APS.